Gene therapy involves altering the body’s cells to fight diseases. Mesothelioma gene therapy is being used as a treatment option for patients diagnosed with malignant mesothelioma. Gene therapy for mesothelioma is experimental, but clinical trials hold great potential for future breakthroughs.
Diagnosed with mesothelioma? Get a free guide to learn about the latest treatment options.
Access information on top mesothelioma treatments.
All types of cancer cells appear to have at least one essential thing in common: They have faulty genes. At the center of every cell in our bodies, there is a nucleus containing thousands of genes made of DNA. Genes are coded instructions for making proteins, the molecules that control how cells work.
Gene Therapy Facts
Broad category including several experimental treatment approaches
Involves genetically modifying cancer cells, viruses or immune cells
Bears risk of severe side effects and complications
Available to mesothelioma patients through clinical trials
A cell with healthy DNA will perform its function in the body, create new cells as needed and destroy itself when it is damaged beyond repair. However, when a carcinogen such as asbestos damages the DNA in a cell, it may cause the cell to grow and divide out of control, leading to cancer.
Many researchers believe that just as faulty genes are the key to cancer formation, modified genes may be the key to cancer treatment. Mesothelioma researchers are hopeful that gene therapy will bring us closer to a cure for mesothelioma.
“Gene therapy” is a broad category that refers to several emerging treatment approaches. They involve the novel science of genetic modification. It wasn’t until recently in 2017 that the U.S. Food and Drug Administration (FDA) approved a gene-therapy-based cancer treatment for the first time.
Most gene therapies for mesothelioma have shown limited effectiveness. Or they caused severe side effects and risks of complications. For this reason, all types of gene therapy for mesothelioma are experimental. They are only available through clinical trials.
The most obvious gene therapy approach is to fix the genetic fault that causes cells to become cancerous in the first place. To perform this medical feat, however, scientists have to overcome two major challenges.
First, researchers have not been able to pinpoint a specific gene that can stop the progression of mesothelioma in most patients. The likeliest candidates are natural “tumor-suppressing genes.” They prevent genetic mutations or ensure mutant cells self-destruct before they grow into tumors.
The p53 gene, the BAP1 gene and microRNA gene 16 have all been studied as genes that may be able to stop the progression of mesothelioma.
Second, inserting these tumor-suppressing genes requires a microscopic delivery vehicle. Called vectors, they can penetrate deep into a tumor. Genetically modified viruses and nanoparticles are both in development as gene therapy vectors.
Patients with malignant pleural mesothelioma may be turning to orally inhalable gene therapy in the future, easing the treatment burden for this cancer with…
Vectors could also insert artificial “suicide genes” into cancer cells.
Researchers want to develop a vector that infects all the cells in a tumor while leaving the rest of the body’s cells alone. It would enable a special form of targeted chemotherapy called suicide gene therapy.
The suicide gene causes cancer cells to produce an enzyme. It converts an otherwise harmless drug into a lethal toxin, so the drug kills cancer cells while leaving healthy cells unharmed.
Find Immunotherapy Clinical Trials Today
Sign Up Now
Engineering Viruses to Target Cancer Cells
Rather than trying to alter cellular DNA, some researchers instead focus on modifying deadly viruses to only kill cancer cells. This approach, known as virotherapy, was discovered by accident when doctors noticed many cancer patients who contract measles experience tumor regressions. Since then, scientists have been developing modified versions of the measles virus as an experimental treatment for several types of cancer, including mesothelioma.
In a 2016 trial, researchers injected a special strain of the measles vaccine directly into mesothelioma tumors. It works through viral infection as well as provoking a natural immune system response against the cancer.
Immunotherapy with Genetically Modified T-Cells
The most exciting recent development lies at the intersection of gene therapy and immunotherapy. The first gene therapy for cancer approved by the FDA is known by the brand name Kymriah and is generically referred to as CAR T-cell therapy. Kymriah’s makers call it a “living drug,” because it is produced by extracting the patient’s own immune cells and reprogramming them to target cancer.
In 2021, researchers concluded that anti-mesothelin CAR T-cells are effective. Future research will combine it with checkpoint inhibitors or other therapy. Scientists are hopeful that this new therapy will improve mesothelioma prognosis.
CAR T-cell therapy is a targeted cancer treatment. But it also has significant limitations. Kymriah is FDA-approved only for leukemia, it is extremely expensive, and it comes with the risk of severe side effects. This technology has the potential to improve outcomes for mesothelioma patients in the future.
Recommended Reading
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592
Who Am I Calling?
Calling this number connects you with a Patient Advocate at The Mesothelioma Center, the nation's most trusted mesothelioma resource.
Our Patient Advocates can help guide you or your loved one through the steps to take after a mesothelioma diagnosis. Our team has a combined experience of more than 30 years in assisting cancer patients, and includes a medical doctor, an oncology registered nurse and a U.S. Navy veteran.
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Reviewed
Asbestos.com is the nation’s most trusted mesothelioma resource
The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.
Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.
More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.
About The Mesothelioma Center at Asbestos.com
Assisting mesothelioma patients and their loved ones since 2006.
Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
A+ rating from the Better Business Bureau.
5-star reviewed mesothelioma and support organization.
My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family.
Dr. Andrea Wolf is the Director of the New York Mesothelioma Program at Mount Sinai in New York City. She focuses on multidisciplinary treatment, clinical research, community outreach and education.
Fact-checked and verified content:
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Please read our editorial guidelines to learn more about our content creation and review process.
